Antares Pharma, Inc., develops and commercializes parenteral therapeutic products using advanced drug delivery systems for improved safety and efficacy, reduced side effects, and enhanced patient comfort and adherence. We apply our drug delivery systems in collaborations with pharmaceutical partners to enhance our partners'_ drug compounds. We believe that we offer a distinct value to patients, physicians, pharmaceutical partners and our shareholders.

Our products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance. We focus on self-injection pharmaceutical products and technologies and topical gel -based products. Our subcutaneous injection technology platforms include Vibex» disposable pressure-assisted auto injectors, Vision¬ reusable needle-free injectors, and disposable multi-use pen injectors.